LearnGlossaryMarketStocksSuperinvestorsSign in

PACB

Pacific Biosciences of California, Inc.

Healthcare · $503M market cap

Verdict

We can't put a fair value on PACB right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-2.4% a year✗
Sales growth12.2% a year✓
Free cash flow growth—?
Return on invested capital-45.1%✗

Follow PACB

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

None of the investors we track holds PACB right now. In Q1 2026, 1 sold out. Who we track

Moves in Q1 2026

Sold out: Polen Capital Management

About Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges. At the heart of its offerings are the proprietary PacBio Sequencing Systems, designed for executing, monitoring, and interpreting biochemical sequencing reactions. Complementing these instruments are…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works